PLX Net Income Growth
Protalix Biotherapeutics Inc · Net Income Growth
PLX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported2203.05%period ending
PLX Quarterly Net Income YoY % (-766.67% → 2203.05%)
Year-over-year change
High-resolution chart · PNG
PLX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 2,203.0488% | |
| 606.1343% | |
| -184.7552% | |
| -27.225% | |
| 107.4444% | |
| 21.2405% | |
| 207.4454% | |
| 274.73% | |
| -111.3915% | |
| -46.7582% | |
| -61.6043% | |
| 48.0796% | |
| 462.5609% | |
| -36.9641% | |
| 43.9028% | |
| 15.0512% | |
| 52.5487% | |
| 58.2466% | |
| -1,779.3451% | |
| 5.364% | |
| -170.8675% | |
| -428.4343% | |
| 36.4261% | |
| -24.6348% | |
| 46.4032% | |
| 122.9488% | |
| -97.0248% | |
| 33.1079% | |
| 8.4968% | |
| -0.3454% | |
| 164.5994% | |
| 53.4668% | |
| -1,980.4444% | |
| 87.7612% | |
| -477.0198% | |
| -56.8861% | |
| 104.1463% | |
| -587.9274% | |
| 79.7014% | |
| -90.8377% | |
| -114.0209% | |
| -43.9719% | |
| -52.639% | |
| 52.3096% | |
| 17.127% | |
| 18.693% | |
| 22.1957% | |
| -39.3771% | |
| 10.5017% | |
| -69.9838% | |
| -10.2055% | |
| -4.8914% | |
| -31,177.2727% | |
| 26.8123% | |
| -10.8157% | |
| 38.2648% | |
| 100.1607% | |
| -16.8646% | |
| -4.5145% | |
| -258.7308% | |
| -36.331% | |
| 36.4928% | |
| 42.9031% | |
| 58.0251% | |
| -85.0193% | |
| -53.4825% | |
| -127.129% | |
| 9.2672% | |
| -28.3282% | |
| -1.3691% | |
| -28.1622% | |
| -36.8732% | |
| 53.8016% | |
| -48.2029% | |
| 44.8339% | |
| -89.916% | |
| -167.1141% | |
| -121.2957% | |
| -46,756.4232% | |
| -7,722.5756% | |
| -26,723.732% | |
| -14,951.1682% | |
| 37.072% | |
| 26.2047% | |
| 78.1767% | |
| 61.1958% | |
| 31.7037% | |
| -34.2076% | |
| -96.5586% | |
| 17.8348% | |
| 7.0123% | |
| -0.3047% | |
| 7.4341% | |
| 9.1476% | |
| 11.3985% | |
| 33.4547% | |
| 38.7404% | |
| 79.2105% | |
| 13.2185% | |
| -488.9336% |